Indeed, the patient from whom the LU-01-1377 tumor originated had a history of osimertinib treatment, and the LU-01-1377 xenograft tumor model exhibited resistance to EGFR-TKI inhibitors (erlotinib, afatinib, and osimertinib; data not shown). The gene discussed is EGFR; the disease is neoplasm.